EP Europace · 2014 · 10 citations · 26 references
MedicineCardiologyPharmacologyClinical PharmacologyElectrophysiologyPharmacodynamicsAtrial FibrillationCardiac MedicationsCardiac PharmacotherapyCardiac PhysiologyCardiovascular PharmacologyHeart FailureAntiarrhythmic Drug EffectsAtrial Fibrillation PathophysiologyConduction Time MeasurementsEpicardial MappingFlecainide TherapyPharmacodynamics Of Antiarrhythmic DrugsSystolic Blood PressureVentricular Conduction
AIMS: About one-third of patients with mild dyssynchronous heart failure suffer from atrial fibrillation (AF). Drugs that convert AF to sinus rhythm may further slowdown ventricular conduction. We aimed to investigate the electrophysiological and haemodynamic effects of vernakalant and flecainide in a canine model of chronic left bundle branch block (LBBB). METHODS AND RESULTS: Left bundle branch block was induced in 12 canines. Four months later, vernakalant or flecainide was administered using a regime, designed to achieve clinically used plasma concentrations of the drugs, n = 6 for each drug. Epicardial electrical contact mapping showed that both drugs uniformly prolonged myocardial conduction time. Vernakalant increased QRS width significantly less than flecainide (17 ± 13 vs. 34 ± 15%, respectively). Nevertheless, both drugs equally decreased LVdP/dtmax by ∼15%, LVdP/dtmin by ∼10%, and left ventricular systolic blood pressure by ∼5% (P = n.s. between drugs). CONCLUSIONS: Vernakalant prolongs ventricular conduction less than flecainide, but both drugs had a similar, moderate negative effect on ventricular contractility and relaxation. Part of these reductions seems to be related to the increase in dyssynchrony.
26
Prevalence of Diagnosed Atrial Fibrillation in Adults
Alan S. Go, Elaine M. Hylek, Kathleen A. Phillips et al. · JAMA · 2001 · 6.2K citations
A. John Camm, Paulus Kirchhof, Gregory Y.H. Lip et al. · European Heart Journal · 2010 · 5.9K citations · Full text
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
A. John Camm, Gregory Y.H. Lip, Raffaele De Caterina et al. · EP Europace · 2012 · 3.8K citations · Full text
Guidelines for the management of atrial fibrillation
A. John Camm, Paulus Kirchhof, Gregory Y.H. Lip et al. · EP Europace · 2010 · 1.7K citations · Full text